Related Topics


Companies




  

Company: Sanofi-aventis

Press releases and articles
September 07. 2010
GSK R&D head says no plan to bid for Genzyme-paper
September 06. 2010
Sanofi prepared to raise Genzyme bid: report
September 03. 2010
Scenarios: Possible outcomes of Sanofi's bid for Genzyme
September 03. 2010
Sanofi-aventis publishes positive trial data for MS drug
September 02. 2010
Deloitte Recap honors Sanofi-aventis and Exelixis with the Allicense 2010 Breakthrough Alliance Award
September 02. 2010
Analysis: Genzyme units attract interest, what about Sanofi?
September 01. 2010
Why Amgen should buy Genzyme
September 01. 2010
Genzyme CEO open to sale, not at $69 a share
September 01. 2010
Largest atrial fibrillation registry reveals poor AF control and high rates of cardiovascular hospitalization
August 31. 2010
Shocker: Sanofi's interested in Genzyme
August 30. 2010
Multaq first-line option in new 2010 ESC guidelines for the management of Atrial Fibrillation
August 30. 2010
Genzyme confirms receipt of unsolicited proposal
August 30. 2010
Sanofi-aventis announces non-binding offer to acquire Genzyme
August 30. 2010
Teriflunomide significantly reduced annualized relapse rate and was well tolerated in MS patients
August 27. 2010
FDA accepts Sanofi Pasteur's application to expand indication of Menactra vaccine to infants and toddlers
August 26. 2010
FDA requires label changes for flu vaccines to highlight latex concerns
August 26. 2010
Judge refuses to block generic Lovenox
August 26. 2010
Sanofi top 2 shareholders seen wary on Genzyme bid
August 24. 2010
Sanofi-Aventis sues FDA to stop generic blood-thinner drug
August 24. 2010
Genzyme, Sanofi at odds over threshold price
August 23. 2010
Sanofi donates nearly $100,000 for Haiti relief efforts
August 23. 2010
Sanofi's BSI-201 tipped for success in triple negative breast cancer
August 20. 2010
Suit aims to block Genzyme acquisition
August 18. 2010
US judge to rule 'soon' on generic blood thinner
August 16. 2010
Gene may have shown Acomplia risk
August 16. 2010
Sanofi seeks efficiencies with new model
August 11. 2010
When are the Biosimilars Coming: Clues from Lovenox, Copaxone, Teva, and FDA
August 11. 2010
Sanofi-aventis Establishes Research Alliance with Scripps Genomic Medicine
August 10. 2010
Sanofi-aventis has announced the appointment of Dr Ian Weatherhead as its new UK-based director of communications.
August 10. 2010
Sanofi faces long summer haggling over Genzyme bid
August 06. 2010
Teva copy of Lovenox may be close; Momenta falls
August 06. 2010
Staff, investors left in dark at Sanofi, Genzyme
August 04. 2010
White knight could be elusive for Genzyme
August 04. 2010
Sanofi investors oppose big hike in Genzyme bid
August 03. 2010
sanofi-aventis: availability on line of the Group’s half-year financial report for 2010
August 02. 2010
FDA finds problems at Sanofi vaccine plant
August 02. 2010
Sanofi CEO targeting everything but blockbusters
August 02. 2010
Sanofi Pasteur begins shipping influenza vaccine in US for 2010-2011 season
July 30. 2010
Sanofi CEO pledges disciplined M&A, silent on Genzyme
July 28. 2010
sanofi-aventis and Merck appoint Raul Kohan as CEO for the New Animal Health Joint Venture
July 28. 2010
Sanofi-Aventis circles Genzyme for potential deal
July 23. 2010
Merrimack Pharmaceuticals and sanofi-aventis initiate enrollment in a phase 2 combination study of MM-121 and exemestane in breast cancer
July 20. 2010
For acute coronary syndrome treatment, more than half of surveyed interventional cardiologists who prescribe high dose Plavix consider it to be comparable in efficacy to Effient
July 19. 2010
Sanofi-aventis makes Jevtana available in US
July 15. 2010
Sanofi-Aventis and Novalar file marketing authorization application for OraVerse in five key European countries
July 12. 2010
Sanofi-Aventis engages future pharmacists in Egypt
July 12. 2010
Institute for OneWorld Health moves closer to increasing supply of accessible, affordable ingredient for treatment for malaria
July 07. 2010
Is sanofi-aventis On the Acquisition Path?
July 07. 2010
Pharming signs manufacturing deal with Sanofi-Aventis
July 05. 2010
Size alone is not the right cure for Sanofi